It is a clinical requirement
In 2024, the ozempic segment accounted for the largest market share
So basically what this is doing, is taking the science of aging, which is formidable, big advances, and using that not to come up with some magical potion which doesn't exist for people, but rather to use those advances, so that we can take the big three, heart, cancer and neurodegenerative, mainly Alzheimer's
Avoiding measurement errors Three common mistakes ruin unit accuracy
Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials
Many insurance companies will only cover the fee if its prescribed for diabetes, not weight loss